Xenopsin-Related Peptide 2 (XP-2) trifluoroacetate salt
Modify Date: 2024-01-19 17:29:59
Xenopsin-Related Peptide 2 (XP-2) trifluoroacetate salt structure
|
Common Name | Xenopsin-Related Peptide 2 (XP-2) trifluoroacetate salt | ||
|---|---|---|---|---|
| CAS Number | 117442-29-2 | Molecular Weight | 1193.44000 | |
| Density | N/A | Boiling Point | N/A | |
| Molecular Formula | C60H88N16O10 | Melting Point | N/A | |
| MSDS | N/A | Flash Point | N/A | |
Use of Xenopsin-Related Peptide 2 (XP-2) trifluoroacetate saltXenopsin-Related Peptide 2 (XP-2) is an avian counterpart to amphibian Xenopsin (HY-P0253). Xenopsin-Related Peptide 2 displays abilities to release histamine from isolated rat mast cells and is as effective as synthetic Bradykinin (HY-P0206)[1]. |
| Name | xenopsin |
|---|---|
| Synonym | More Synonyms |
| Description | Xenopsin-Related Peptide 2 (XP-2) is an avian counterpart to amphibian Xenopsin (HY-P0253). Xenopsin-Related Peptide 2 displays abilities to release histamine from isolated rat mast cells and is as effective as synthetic Bradykinin (HY-P0206)[1]. |
|---|---|
| Related Catalog | |
| In Vitro | Synthetic and native preparations of Xenopsin-Related Peptide 2 (XP-2) increases vascular permeability in rats and released histamine from isolated rat mast cells at submicromolar concentrations[1]. |
| In Vivo | Xenopsin-Related Peptide 2 (XP-2) (0.3-3000 nM; intradermally; 50 μL) induces skin vascular permeability in rats[1]. Animal Model: Rats weighing 300-400 g[1] Dosage: 0.3-3000 nM Administration: Intradermal injection, 50 μL Result: Increased skin vascular permeability in a dose-dependent manner. |
| References |
| Molecular Formula | C60H88N16O10 |
|---|---|
| Molecular Weight | 1193.44000 |
| Exact Mass | 1192.69000 |
| PSA | 410.93000 |
| LogP | 5.51880 |
| Xenopsin-Related Peptide 2 (XP-2) |